MSFT 425.025 -0.9035% AAPL 220.43 0.8648% NVDA 115.85 1.4004% GOOGL 172.44 -0.1101% GOOG 174.27 -0.0573% AMZN 182.99 1.1945% META 460.09 -0.2558% AVGO 152.64 0.859% TSLA 224.8499 4.102% TSM 161.61 1.1327% LLY 823.56 -4.2238% V 257.56 1.3338% JPM 209.535 0.453% UNH 562.83 0.5502% NVO 129.31 -1.7401% WMT 70.206 -0.5581% LVMUY 143.15 0.9022% XOM 116.85 1.5999% LVMHF 714.04 0.4982% MA 436.96 1.0429%

Element Nutritional Sciences Inc

Consumer Defensive US ELNSF

NoneUSD
-(-%)

Last update at 2024-05-01T21:04:53.941389Z

Day Range

--
LowHigh

52 Week Range

0.020.19
LowHigh

Fundamentals

  • Previous Close 0.15
  • Market Cap5.30M
  • VolumeNone
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-6.29951M
  • Revenue TTM0.27M
  • Revenue Per Share TTM0.002
  • Gross Profit TTM 0.79M
  • Diluted EPS TTM-0.05

Financials

Income Statement

Balancesheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Income before tax -10.34713M -8.77953M -7.71632M - -
Minority interest - - - - -
Net income -10.34713M -8.77953M -7.71632M - -
Selling general administrative 9.25M 10.14M 3.72M - -
Selling and marketing expenses - - - - -
Gross profit -1.08266M 0.17M 0.16M - -
Reconciled depreciation 0.03M 0.08M 0.15M - -
Ebit - -10.21310M -3.89260M -1.43164M -1.37838M
Ebitda -10.17877M -8.67062M -7.53198M - -
Depreciation and amortization - - - - -
Non operating income net other - - - - -
Operating income -10.38268M -10.06549M -3.75015M - -
Other operating expenses - - - - -
Interest expense 0.13M 0.03M 0.03M 0.00000M 0.00000M
Tax provision 0.00000M 0.00000M 0.00000M - -
Interest income - - - - -
Net interest income -0.16333M -0.05224M -0.05297M - -
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense - - - - -
Total revenue 4.00M 2.36M 0.98M - -
Total operating expenses 14.38M 12.42M 4.73M - -
Cost of revenue 5.08M 2.18M 0.82M - -
Total other income expense net 0.20M 1.34M -3.91320M - -
Discontinued operations - - - - -
Net income from continuing ops -10.34713M -8.77953M -7.71632M - -
Net income applicable to common shares - - - -1.49680M -1.88153M
Preferred stock and other adjustments - - - - -
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Total assets 2.65M 5.00M 1.30M - -
Intangible assets - - - - -
Earning assets - - - - -
Other current assets - - - - -
Total liab 7.52M 3.69M 3.81M - -
Total stockholder equity -4.86913M 1.30M -2.50462M - -
Deferred long term liab - - - - -
Other current liab - - - 0.00010M 0.00010M
Common stock - - - 0.00012M 0.00012M
Capital stock 23.98M 20.45M 10.93M - -
Retained earnings -33.10328M -22.75615M -13.97662M -6.16030M -4.66350M
Other liab - - - - -
Good will - - - - -
Other assets - - - - -
Cash 0.00345M 0.49M 0.09M - -
Cash and equivalents - - - - -
Total current liabilities 7.50M 3.66M 3.70M 3.83M 3.63M
Current deferred revenue - - - - -
Net debt 1.43M 0.23M 1.18M - -
Short term debt - - - - -
Short long term debt 1.44M 0.69M 1.21M - -
Short long term debt total - - - - -
Other stockholder equity - - - - -
Property plant equipment - - - 0.18M 0.31M
Total current assets 2.56M 4.92M 1.13M 0.80M 0.40M
Long term investments - - - - -
Net tangible assets - - - -6.16019M -4.66338M
Short term investments - - - - -
Net receivables 0.11M 0.16M 0.41M 0.28M 0.13M
Long term debt - 0.03M 0.05M - -
Inventory 1.45M 3.19M 0.34M 0.30M 0.10M
Accounts payable 5.85M 2.97M 2.43M 0.42M 0.27M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income - - - - -
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other - - - - -
Deferred long term asset charges - - - - -
Non current assets total 0.09M 0.08M 0.17M - -
Capital lease obligations 0.03M 0.00000M 0.11M - -
Long term debt total - - - - -
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Investments -0.02038M -0.03732M 1.85M - -
Change to liabilities - - - 0.15M -0.08766M
Total cashflows from investing activities - - - -0.02438M -0.00144M
Net borrowings - - - -0.05468M 0.03M
Total cash from financing activities 4.29M 10.55M 0.22M 1.62M 1.44M
Change to operating activities - - - -0.06257M -0.05256M
Net income -10.34713M -8.77953M -7.71632M -1.49680M -1.88153M
Change in cash -0.23260M 0.57M -0.08855M -0.00728M 0.09M
Begin period cash flow 0.49M 0.09M 0.10M - -
End period cash flow 0.00345M 0.49M 0.09M 0.10M -
Total cash from operating activities -4.50599M -9.94211M -2.15227M -1.60322M -1.35103M
Issuance of capital stock 3.50M 12.12M 0.00000M - -
Depreciation 0.03M 0.08M 0.15M 0.15M 0.15M
Other cashflows from investing activities - - - - -
Dividends paid - - - - -
Change to inventory 1.36M -2.82215M -0.05233M -0.19375M 0.06M
Change to account receivables - - - -0.15127M -0.04559M
Sale purchase of stock - - - - -
Other cashflows from financing activities - - - - -
Change to netincome - - - - 0.50M
Capital expenditures 0.02M 0.04M 0.00999M 0.02M 0.00144M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital 4.18M -2.81334M 1.00M - -
Stock based compensation 0.99M - - - -
Other non cash items 0.03M 1.58M 2.22M - -
Free cash flow -4.52936M -9.97943M -2.16227M - -

Peer Comparison

Sector: Consumer Defensive Industry: Packaged Foods

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
ELNSF
Element Nutritional Sciences Inc
- -% - - - 19.98 5.40 29.44 -1.233
NSRGF
Nestle SA
-3.26 3.13% 100.82 26.86 18.76 3.13 7.10 3.81 21.70
NSRGY
Nestle SA ADR
-4.32 4.12% 100.48 26.82 18.66 3.18 7.07 3.81 21.70
KHC
Kraft Heinz Co
0.32 0.95% 33.37 15.59 11.79 1.64 0.88 2.34 11.32
DANOY
Danone PK
0.06 0.47% 12.70 28.42 16.39 1.44 2.23 1.85 12.41

Reports Covered

Stock Research & News

Profile

Element Nutritional Sciences Inc., a nutraceutical company, develops nutritional products in Canada and the United States. The company offers Rejuvenate, a proprietary formulation to assist in the rebuilding, restoration, and rejuvenation of natural loss of muscle mass due to aging or other medical conditions; JAKTRX performance supplement products; and PROMINO, an elite performance supplement for both professional and amateur athletes to accelerate muscle recovery, build strength, and accelerate recovery from injury. The company offers its products under the Rejuvenate and JAKTRX brand names. It also engages in retailing of its products through stores and online. The company was formerly known as Element Nutrition Inc. and changed its name to Element Nutritional Sciences Inc. in June 2021. Element Nutritional Sciences Inc. is based in Burlington, Canada.

Element Nutritional Sciences Inc

1100 Walkers Line, Burlington, ON, Canada, L7N 2G3

Key Executives

Name Title Year Born
Mr. Stuart A. Lowther Chairman, Pres & CEO 1964
Mr. Shaun Power C.A., CPA CFO, Corp. Sec. & Director 1970
Mr. Stephen Brown Chief Operating Officer NA
Mr. Dean Pipher Chief Sales Officer NA
Mr. Vito Sanzone Chief Marketing Officer NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.